Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® Regimen

Inclusion Criteria: * Male and female children aged ≥6 months to ≤6 years * Baseline PEST score of 3- 4 * Diagnosis of mild to moderate atopic dermatitis, with grading of 3 to11, as per the NESS * Diagnosis of current flare (increased dryness, itching, redness, swelling and general irritability) at baseline visit according to Investigator's judgement * Patients who have not visited the dermatologist before (dermatologist-naïve) * Agree to participate and provide written consent by parent or guardian (and assent if applicable) Exclusion Criteria: * History of severe episodes of atopic dermatitis (for example: oozing, crusts) * Clinical signs of skin infection (viral, bacterial or fungal) * Grading of \>11 as defined by the Nottingham Eczema Severity Score (NESS) within 3 months prior to study inclusion * Known reaction or allergy to test drug or excipients or steroids * History of cutaneous or systemic viral (including HIV or AIDS), cutaneous mycotic or cutaneous bacterial disease requiring a topical or systemic therapy during the study period * Patients who are receiving any investigational drug or who have taken part in a clinical study with an investigational drug within three months prior to the start of study treatment * The patient has been exposed to below therapy within the set timeframe: i. Systemic administration of corticosteroid - four weeks; ii. Systemic administration of immunosuppressive drugs - four weeks; iii. UV therapy four weeks * Any serious medical condition which, in the opinion of the investigator, may interfere with the evaluation of the results * Parents/guardians may be unable to complete the patient diaries or questionnaires